Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 12 studies | 27% ± 13% | |
memory B cell | 7 studies | 20% ± 4% | |
naive B cell | 7 studies | 18% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 20% ± 5% | |
natural killer cell | 4 studies | 18% ± 3% | |
regulatory T cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of FCRL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 224.37 | 567 / 578 | 46% | 1.65 | 530 / 1155 |
spleen | 100% | 6260.43 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 915.48 | 908 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 123.02 | 28 / 29 |
liver | 82% | 72.88 | 186 / 226 | 9% | 0.46 | 38 / 406 |
kidney | 51% | 78.31 | 45 / 89 | 28% | 0.97 | 255 / 901 |
thymus | 49% | 162.79 | 320 / 653 | 23% | 1.27 | 139 / 605 |
intestine | 51% | 688.67 | 495 / 966 | 19% | 1.11 | 100 / 527 |
breast | 33% | 19.02 | 151 / 459 | 33% | 1.23 | 368 / 1118 |
stomach | 34% | 32.81 | 122 / 359 | 29% | 1.35 | 82 / 286 |
tonsil | 0% | 0 | 0 / 0 | 56% | 2.73 | 25 / 45 |
prostate | 43% | 55.95 | 106 / 245 | 10% | 0.29 | 48 / 502 |
adipose | 51% | 47.24 | 614 / 1204 | 0% | 0 | 0 / 0 |
bladder | 29% | 58.33 | 6 / 21 | 20% | 1.25 | 99 / 504 |
skin | 2% | 1.07 | 36 / 1809 | 44% | 2.86 | 206 / 472 |
esophagus | 20% | 20.80 | 296 / 1445 | 25% | 0.79 | 46 / 183 |
uterus | 21% | 11.07 | 36 / 170 | 20% | 0.52 | 94 / 459 |
pancreas | 2% | 0.93 | 6 / 328 | 38% | 1.71 | 67 / 178 |
heart | 19% | 10.65 | 162 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 15% | 31.06 | 195 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 11% | 4.40 | 29 / 258 | 0% | 0.01 | 1 / 230 |
ovary | 7% | 2.93 | 12 / 180 | 4% | 0.06 | 16 / 430 |
eye | 0% | 0 | 0 / 0 | 10% | 0.29 | 8 / 80 |
brain | 3% | 1.05 | 69 / 2642 | 1% | 0.31 | 6 / 705 |
muscle | 1% | 0.40 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045577 | Biological process | regulation of B cell differentiation |
GO_0090279 | Biological process | regulation of calcium ion import |
GO_0050859 | Biological process | negative regulation of B cell receptor signaling pathway |
GO_0034163 | Biological process | regulation of toll-like receptor 9 signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0050864 | Biological process | regulation of B cell activation |
GO_0006955 | Biological process | immune response |
GO_0002638 | Biological process | negative regulation of immunoglobulin production |
GO_1905184 | Biological process | positive regulation of protein serine/threonine phosphatase activity |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0007338 | Biological process | single fertilization |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0031528 | Cellular component | microvillus membrane |
GO_0009986 | Cellular component | cell surface |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0019900 | Molecular function | kinase binding |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0019902 | Molecular function | phosphatase binding |
Gene name | FCRL3 |
Protein name | Fc receptor like 3 Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (MAIA) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c) |
Synonyms | FCRH3 IFGP3 SPAP2 IRTA3 |
Description | FUNCTION: Promotes TLR9-induced B-cell proliferation, activation and survival but inhibits antibody production and suppresses plasma cell differentiation. Enhances activation of NF-kappa-B and MAPK signaling pathways in TLR9 stimulated B-cells . Has inhibitory potentional on B-cell receptor (BCR)-mediated signaling, possibly through association with SH2 domain-containing phosphatases. Inhibits cell tyrosine phosphorylation, calcium mobilization and activation-induced cell death induced through BCR signaling . Regulatory T-cells expressing FCRL3 exhibit a memory phenotype, are relatively nonresponsive to antigenic stimulation in presence of IL2 and have reduced capacity to suppress the proliferation of effector T-cells . Acts as a human-specific epitope on the cell surface of oocytes (oolemma) and plays a role during sperm-egg adhesion and fusion . Interacts with the IZUMO1-IZUMO1R/JUNO sperm-egg complex and replaces IZUMO1R/JUNO as IZUMO1 receptor during fertilization, thereby permitting species-specific gamete fusion . . |
Accessions | ENST00000492769.5 [Q96P31-3] R4GNJ6 Q96P31 ENST00000485028.5 [Q96P31-1] ENST00000368184.8 [Q96P31-1] ENST00000477837.5 [Q96P31-2] ENST00000496769.1 ENST00000368186.9 [Q96P31-6] |